Download FREE Report Sample
Download Free sampleSickle Cell Disease, an inherited blood disorder, often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal hemoglobin S variant.?Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging tissues, and ultimately leading to many of the complications of Sickle Cell Disease.
Sickle Cell Anemia Testing Screening Market contains market size and forecasts of Sickle Cell Anemia Testing & Screening in Global, including the following market information:
Global Sickle Cell Anemia Testing & Screening Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sickle Cell Anemia Testing & Screening market was valued at 267.3 million in 2021 and is projected to reach US$ 409.4 million by 2028, at a CAGR of 6.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hemoglobin Electrophoresis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sickle Cell Anemia Testing & Screening include STRECK, INC., BioMedomics Inc., Laboratory Corporation of America Holdings, Silver Lake Research Corporation, HEMEX HEALTH, Bio-Rad Laboratories, Inc., PerkinElmer Inc. and Quest Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sickle Cell Anemia Testing & Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sickle Cell Anemia Testing & Screening Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sickle Cell Anemia Testing & Screening Market Segment Percentages, by Type, 2021 (%)
Hemoglobin Electrophoresis
High-performance Liquid Chromatography (HPLC)
Point-of-Care Tests
Other Tests
Global Sickle Cell Anemia Testing & Screening Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sickle Cell Anemia Testing & Screening Market Segment Percentages, by Application, 2021 (%)
Newborn Screening (12 months and below)
Adult Screening (25 to 60 years)
Other Age Groups (1 to 25 & above 60 years)
Global Sickle Cell Anemia Testing & Screening Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sickle Cell Anemia Testing & Screening Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sickle Cell Anemia Testing & Screening revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sickle Cell Anemia Testing & Screening revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
STRECK, INC.
BioMedomics Inc.
Laboratory Corporation of America Holdings
Silver Lake Research Corporation
HEMEX HEALTH
Bio-Rad Laboratories, Inc.
PerkinElmer Inc.
Quest Diagnostics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
